Excisional biopsy with margin control for oral cancers

College of Medicine, Chang Gung University, Taoyuan, Taiwan
Head & Neck (Impact Factor: 2.64). 11/2010; 32(11):1528 - 1533. DOI: 10.1002/hed.21359
Source: PubMed


This study was undertaken to show how an excisional biopsy procedure can be used to remove the entire specimen for oral lesions with difficult diagnoses.Methods
We retrospectively reviewed 52 cases with 56 oral lesions either suspected to be malignant or with a preliminary controversial diagnosis. These were treated by excisional biopsy with frozen section intraoperatively between January 2003 and June 2008.ResultsTwenty-eight of 56 lesions were diagnosed with malignancy. We found a high underdiagnosis rate (7 of 12) in patients who had a preliminary controversial diagnosis. Twenty-one patients without preoperative biopsy were diagnosed to have malignancies. Of the 28 malignant cases, all surgical margins were negative. Neck ultrasound scans with fine-needle aspiration cytology was carried out and no patient demonstrated simultaneous neck metastasis. One patient died of locoregional recurrence. Two patients died of a second primary cancer.Conclusion
Excisional biopsy with margin control is useful both in diagnosis and treatment of oral cancers. © 2010 Wiley Periodicals, Inc. Head Neck, 2010

Full-text preview

Available from:
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leukoplakia of the lateral tongue is frequently associated with the risk of malignancy. Although incisional biopsy is accepted as a standard technique for evaluation, the possibility of underdiagnosis, and therefore missed diagnosis of malignancy, remains at all times. The aim of this study was to determine the rate of underdiagnosis by incisional biopsy for leukoplakia of the lateral tongue and to elucidate the underlying cause of for underdiagnosis. Twenty-two patients with leukoplakia in the lateral tongue who had undergone excisional biopsy for suspicion of malignancy were included in the study. Pathology was reviewed and classified into 'no dysplasia,''dysplasia,' and 'carcinoma'. Underdiagnosis was defined as a change of diagnosis to a graver classification following excisional biopsy. To analyze the factors contributing to underdiagnosis, incisional and excisional biopsy specimens were re-evaluated. Of the 22 patients with leukoplakia of the lateral tongue, 59.1% had coexistent malignancy, including nine squamous cell carcinomas and four verrucous carcinomas. Incisional biopsy resulted in underdiagnosis in 73.3% of the cases. Underdiagnosis was attributable to three common errors, which were mis-selection of sampling site within a large area of leukoplakia, error in pathology specimen preparation owing to small specimen size, and superficial biopsy frequently associated with punch biopsy. Leukoplakia of the lateral tongue is highly coexistent with malignancy, and incisional biopsy frequently leads to underdiagnosis. Therefore, complete excision with adequate margin is warranted for leukoplakia of the lateral tongue, preferably under general anesthesia, which could be performed with minimal morbidity and function preservation.
    Journal of Oral Pathology and Medicine 11/2011; 41(5):384-8. DOI:10.1111/j.1600-0714.2011.01106.x · 1.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To review the recent literature on health-related quality of life (HRQOL) in head and neck cancer (HNC) patients. HRQOL is an important part of well designed clinical trials. HRQOL seems to be an independent predictor of survival, but this association may be influenced by various cancer-related, personal, biological, psychobehavioural, physical, lifestyle-related, and social factors. Less is known about the course of HRQOL over time and about the same above-mentioned possible factors associated with (change in) HRQOL of HNC patients. Symptom management and psychosocial care may be beneficial for HNC patients to improve HRQOL, but more randomized controlled trials are needed. Studies on HRQOL in HNC are most often based on cross-sectional designs. The variability in the outcome measures hampers the generalizability of the results of these studies. Information on HRQOL of caregivers is scarce. Better information on all aspects of the course of HRQOL from diagnosis and treatment to long-term survivorship or death is highly needed in both patients and their caregivers, enabling reliable and valid predictive modelling. More evidence of efficacy of (new) treatment options, symptom management, and psychosocial care is needed, also in the context of increasing long-term survival and growing attention for cancer survivorship.
    Current opinion in otolaryngology & head and neck surgery 01/2012; 20(2):142-7. DOI:10.1097/MOO.0b013e32834f5fd7 · 1.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Oral cancer is a potentially fatal disease with an increasing incidence and an unchanged 5-year mortality rate. Unfortunately, oral cancer is often still late diagnosed, which leads to an increase in the likelihood of functional impairment due to treatment and mortality rate. Definitive diagnosis of oral cancer must be confirmed by scalpel biopsy and histological assessment. However despite its benefits, scalpel biopsy is invasive and it is burdened by a potential morbidity. Furthermore, previous studies have suggested a high degree of intraobserver and interobserver variability regarding the histological evaluation of malignancy. As a consequence, in recent years there has been a growing and persisting demand towards developing new non-invasive, practical diagnostic tools that might facilitate the early detection of oral cancer. The most investigated non-invasive adjunctive techniques are vital staining, autofluorescence, chemiluminescence, narrow band imaging, and exfoliative cytology. Aim of the review is to critically describe these adjunctive aids and, after considering the literature data, an expert opinion on the effectiveness and the possible use of each technique will be provided.
    Current pharmaceutical design 05/2012; 18(34). DOI:10.2174/138161212803307626 · 3.45 Impact Factor
Show more